The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- Why Every Dentist Should Understand Generative AI and Bloom’s Taxonomy
- One-Hour Molecular Brush Biopsy Could Transform Oral Cancer Screening
- Virginia’s New Dental Scaling Law: What It Means for Dental Hygienists, Dental Assistants, and Patient Safety
- Why Orthodontists Are No Longer America’s Highest-Paid Professionals
- MDS Students Must Maintain 80% Biometric Attendance, Says NDC
Archives